XNK Therapeutics
Stephan Meinke received his doctorate degree in 2010 from the University of Heidelberg, Germany for his work on NK cell signalling. Since then he has been working as a researcher at Karolinska Institutet and Karolinska University Hospital with an interest in NK cell biology and transfusion immunology. He holds a position as assistant professor in the Cell and Gene Therapy Group at Karolinska Institutet.
This person is not in any offices
XNK Therapeutics
XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.